SNX24A (4AZ9) Materials & Methods |
Entry clone source: MGC |
SGC Construct ID: SNX24A-c003 |
Vector: pNIC28-Bsa4. Details [PDF ]; Sequence [ FASTA ] or [ GenBank ]. |
DNA sequence: |
Final protein sequence (Tag sequence in lowercase): ^ TEV protease recognition site |
Tags and additions: Cleavable N-terminal His6 tag |
Host: BL21(DE3)-R3-pRARE2. Phage-resistant strain. |
Growth Medium & Induction Protocol: A glycerol stock was used to inoculate 2X60 ml of TB media containing 50 µg/ml kanamycin and 50 µg/ml chloramphenicol, which was placed in a 37°C shaker overnight. The next day this starter culture was used to inoculate 12L of TB media (10 ml starter culture used per 1L) containing 50 µg/ml kanamycin. When the OD600 reached approximately 1.0 the temperature was reduced to 18°C and after a further 30 minutes the cells were induced by the addition of 0.1 mM IPTG. The expression was continued overnight. Cells were harvested by centrifugation at 16,000 RPM after which the supernatant was poured out and the cell pellet either placed in a -80°C freezer or used directly for purification. |
Cell Lysis: Cell pellets were dissolved in approximately 50ml lysis buffer and broken by passing through the homogeniser (x6) at a constant pressure of 15KPa. The cell debris was pelleted at 16,000 RPM and the supernatant used for further purification |
Column 1: Ni-NTA (5.0 ml volume in a gravity-flow column). |
Column 1 Buffers: |
Column 1 Procedure: The clarified cell extract was incubated with 5.0 ml pre-equilibriated 50% Ni-NTA bead solution for 1 hour at 4°C with rotation after which it was passed through a glass column. The column was then washed with 50ml Binding Buffer (2 x 25ml) and 50 ml Wash Buffer (2 x25 ml). The protein was eluted with 50 ml of Elution Buffer in 5 x 5 ml fractions. |
Column 2: Superdex s200 16/60 Gel Filtration |
Column 2 Buffers: |
Column 2 Procedure: Two separate pools from the Ni-NTA column were created; elution 1 and the combined (BB1+WB1+WB2). Both pools were then concentrated to 5ml and applied separately to the GF column (pre-equilibrated in GF Buffer) at 1.0 ml/min. 1.0 ml fractions were collected. |
Enzymatic Treatment and Purification A test cleavage for both pools showed that the protein is not completely cleaved therefore it was decided not to carry out a TEV-cut overnight and so correspondingly, His-tags were not removed by the Ni-rebind step. |
Column 3: HIGH TRAP -SP |
Column 3 Buffers: |
Column 3 Procedure: Two separate pools from the Ni-NTA column were created; elution 1 and the combined (BB1+WB1+WB2). Both pools were then concentrated to 5ml and applied separately to the GF column (pre-equilibrated in GF Buffer) at 1.0 ml/min. 1.0 ml fractions were collected. |
Concentration: To set up plates the sample was concentrated to 18.1 mg/ml using a 10 kDa mwco concentrator |
Mass spec characterization: |
Crystallization: Crystals were grown by vapour diffusion in sitting drop at 20°C. A sitting drop consisting of 100 nl protein and 50 nl well solution was equilibrated against well solution containing 0.1M tris pH 8.5, 0.2M Magnesium Chloride, 30%(w/v) PEG 4000. Crystals were mounted in the presence of 25% (v/v) glycerol and flash-cooled in liquid nitrogen. |
Data Collection: Resolution: 1.8 Å |